Raynaud's Phenomenon

Last Updated: November 11, 2024

Raynaud’s phenomenon is a disorder associated with vasoconstriction (blood vessel narrowing) in response to cold exposure or emotional stress.

examine-databaseExamine Database

Raynaud's Phenomenon falls under theCardiovascular Healthcategory.

What is Raynaud’s phenomenon?

In response to exposure to the cold, the body restricts blood flow to the skin to preserve its core temperature. People with Raynaud’s phenomenon (also called Raynaud’s syndrome) experience this restriction of blood flow more readily because of an enhanced sensitivity to cold. The areas of the body affected are typically the fingers and toes, although in rare cases Raynaud’s can affect the lips, nose, ear lobes, nipples, or tongue.[1] The restriction of blood flow in people with Raynaud’s is also commonly triggered by emotional stress. Raynaud’s can be categorized as primary (without another underlying cause) or secondary (resulting from complications of another condition).[2][3][4]

What are the main signs and symptoms of Raynaud’s phenomenon?

Raynaud’s phenomenon occurs when flares or “attacks” trigger blood vessels in certain parts of the body to constrict, reducing blood flow and causing pain, numbness, and tingling. The fingers and toes are the most common areas affected, but Raynaud’s can also affect the nose and ears.

During a Raynaud’s attack, loss of blood flow to the affected area causes the tissue to turn a pale white color. As blood in the area loses oxygen, the tissue becomes blue and feels cold and numb. When circulation is restored, the affected areas turn red and become swollen. People may also experience a tingling, burning, or throbbing sensation at this stage. Attacks can last from minutes to hours, but in rare cases Raynaud’s attacks can last for days, causing permanent damage to the affected areas.[1][2]

Severe attacks, which are more common with secondary Raynaud’s phenomenon, can cause ulcers or sores to form on the end of the affected fingers or toes.

How is Raynaud’s phenomenon diagnosed?

When Raynaud’s is suspected, a health care provider will consider risk factors such as the age of onset and location of the affected areas on the body and will evaluate the overall frequency and severity of symptoms. The person’s health history will also be reviewed for the presence of other symptoms that may indicate secondary Raynaud’s caused by another underlying condition.[2]

A technique called nailfold capillary microscopy (NCM) may also be used to differentiate between primary and secondary Raynaud’s. NCM allows the physician to see changes in the structure of the capillaries that may indicate the presence of underlying conditions implicated in secondary Raynaud’s, such as scleroderma or other connective tissue disorders.[5][6][7]

What are some of the main medical treatments for Raynaud’s phenomenon?

The main medical treatments for Raynaud’s are focused on reducing the severity and frequency of attacks and improving blood flow. Early treatments for Raynaud’s typically involve conservative therapies focused on lifestyle changes to avoid the circumstances that trigger attacks. This can include limiting cold exposure, avoiding stimulants such as caffeine[8] or ADHD medications such as Ritalin (methylphenidate)[9], and managing stress.

If conservative treatments fail, the following medications may be used to treat blood vessel constriction:

  • Alpha-receptor blockers[10]
  • Phosphodiesterase inhibitors[11]
  • Calcium-channel blockers[12]
  • Endothelin-1 inhibitors[13]
  • Selective serotonin reuptake inhibitors (SSRIs)[14]
Have any supplements been studied for Raynaud’s phenomenon?

Several supplements have been studied for Raynaud’s phenomenon.

  • Pycnogenol: In a pilot trial comparing pycnogenol supplementation + standard therapy to standard therapy alone in women with primary Raynaud’s, pycnogenol supplementation significantly improved blood flow and reduced symptoms. Pycnogenol also improved tissue oxygen levels and reduced levels of biomarkers for oxidative stress.[15]

  • Fish oil: Fish oil was shown in one study to improve cold tolerance and delay blood vessel constriction in people with Raynaud’s.[16]

  • Essential fatty acids (omega-3 and omega-6): In a cohort of healthy participants, daily supplementation with an essential fatty acid (EFA) supplement for 6 months reduced red blood cell aggregation. Since red blood cell aggregation has been implicated in worsening blood flow to the affected extremities in people with secondary Raynaud’s, the authors speculated that EFA supplements and/or fish oil might be useful for treating Raynaud’s.[17]

  • Beetroot juice: Beetroot juice improved blood flow and blood vessel function and reduced inflammation in people with Raynaud’s.[18]

Additional supplements studied for treating Raynaud’s include L-arginine and N-acetylcystine (NAC). However, neither L-arginine[19][20] nor NAC[21] supplementation were found to improve blood flow in people with Raynaud’s.

How could diet affect Raynaud’s phenomenon?

There haven’t been many studies specifically testing the effect of diets on Raynaud’s. However, some investigators have speculated that foods with circulation-improving properties such as garlic[22] may help to improve blood flow. Additionally, foods that contain caffeine should be avoided, because it decreases blood flow to the extremities.[23]

Are there any other treatments for Raynaud’s phenomenon?

Some alternative, nonpharmaceutical interventions have been used to treat Raynaud’s, including exercise, therapeutic gloves, and laser therapy.[24][25]

Acupuncture has also shown some modest benefits, although it remains to be seen whether it can cause a meaningful reduction in symptoms.[26]

An older study found that immersing the hand in warm water then exposing it to cold increased finger temperatures in people with Raynaud’s,[27] possibly through training the body’s natural ability to constrict and dilate blood vessels in response to environmental conditions.

What causes Raynaud’s phenomenon?

The most common cause of Raynaud’s phenomenon is overactivation of the sympathetic nervous system. This causes an increased release of the neurotransmitter norepinephrine, which binds to and activates adrenergic receptors. When the alpha-2 adrenergic receptors on blood vessels are activated, the smooth muscle tissue that lines the blood vessel walls contracts, causing vasoconstriction (a narrowing of blood vessels).

Excessive blood vessel constriction reduces blood flow to the extremities, which causes the characteristic changes in skin color associated with Raynaud’s as well as pain, tingling, and numbness.

There are two main variants of Raynaud’s: primary and secondary. With primary Raynaud’s, the disorder occurs on its own, independent of any underlying condition. In contrast, secondary Raynaud’s is caused by the presence of another underlying condition, such as lupus, scleroderma, or other autoimmune disorders.[2]

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Raynaud's Phenomenon
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Update History
2024-11-11 00:30:05

All new FAQs were added to this page.

major

We added all new FAQs to this page including:

What is Raynaud’s phenomenon?: A new FAQ was added describing Raynaud’s phenomenon (also called Raynaud’s disorder or Raynaud’s Syndrome). This disorder causes blood vessels in the extremities to inappropriately constrict in response to stress or cold temperatures.  The differences between the different types of Raynaud’s were also discussed. Since secondary Raynaud’s is caused by the presence of another underlying (generally autoimmune) condition, distinguishing between primary and secondary Raynaud’s is important to determine the appropriate treatments.   What are the main signs and symptoms of Raynaud’s phenomenon?: A new FAQ was added that discusses the signs and symptoms of Raynaud’s attacks (also called episodes), and the primary areas of the body that are affected.

How is Raynaud’s phenomenon diagnosed?: A new FAQ was added that discusses diagnostic considerations that health care providers use when Raynaud’s is suspected. Factors health care providers may consider when distinguishing primary vs. secondary Raynaud’s were also noted, including nailfold capillary microscopy (NCM). NCM is a procedure that allows physicians to see changes in the structure of small blood vessels and is an important tool for distinguishing between primary and secondary Raynaud’s.   What are some of the main medical treatments for Raynaud’s?: A new FAQ was added to discuss the main medical treatments for Raynaud’s, which typically are conservative and aimed at limiting or avoiding the conditions that instigate attacks. Differences in treatment strategies for primary vs. secondary Raynaud’s were also discussed, as well as some of the common pharmaceutical treatments.

Have any supplements been studied for Raynaud’s phenomenon?: A new FAQ  was added discussing supplements that have been studied for treating Raynaud’s. Studies have tended to be less rigorous, smaller-scale pilot trials, resulting in some uncertainty in the results.   How could diet affect Raynaud’s phenomenon?: A new FAQ was added discussing diet interventions for Raynaud’s. Although there have not been many studies (or any) testing diet interventions for Raynaud’s some investigators have speculated that foods with circulation-promoting properties may be helpful.   Are there any other treatments for Raynaud’s phenomenon?: A new FAQ was added discussing alternative, non-pharmaceutical treatments for Raynaud’s. Theoretically, interventions that affect the smooth muscle tissue regulating blood vessel narrowing (vasoconstriction) and widening (vasodilation) could help to recalibrate the signaling mechanisms that trigger inappropriate vasoconstriction in people with Raynaud’s, as suggested in a study in the early 1980s testing the effect of finger immersion in warm water followed by cold exposure in people with Raynaud’s.   What causes Raynaud’s phenomenon?: An FAQ was added discussing the mechanisms that trigger Raynaud’s attacks. Raynaud’s is an over-reaction of the sympathetic nervous system, which causes blood vessels in the extremities (fingers and toes but sometimes other parts of the body as well) to constrict inappropriately, cutting off blood flow and leading to low oxygen levels in the affected digits and the characteristic color-change. 

We added three randomized controlled trials and one meta-analysis to the Examine Database.

Written By

Reviewed By

References
  1. ^Raynaud’s phenomenon; USA: National Institute of Arthritis and Musculoskeletal and Skin Diseases, cited Oct. 2024, updated July 2024
  2. ^Musa R, Qurie ARaynaud Disease.StatPearls.(2024 Jan)
  3. ^Ventura I, Reid P, Jan RApproach to Patients with Suspected Rheumatic Disease.Prim Care.(2018 Jun)
  4. ^Pauling JD, Reilly E, Smith T, Frech TMEvolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.Arthritis Care Res (Hoboken).(2019 Aug)
  5. ^Vidal C, Ruano C, Bernardino V, Lavado Carreira P, Lladó A, Santos MC, Gruner H, Panarra A, Riso N, Moraes-Fontes MFClinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative.Acta Med Port.(2018 Jun 29)
  6. ^Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani COutcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis.Swiss Med Wkly.(2017)
  7. ^Mirbod SM, Sugiura HA non-invasive technique for the evaluation of peripheral circulatory functions in female subjects with Raynaud's phenomenon.Ind Health.(2017 Jun 8)
  8. ^Bakst R, Merola JF, Franks AG Jr, Sanchez MRaynaud's phenomenon: pathogenesis and management.J Am Acad Dermatol.(2008 Oct)
  9. ^Meridor K, Levy YSystemic sclerosis induced by CNS stimulants for ADHD: A case series and review of the literature.Autoimmun Rev.(2020 Jan)
  10. ^Cleophas TJ, van Lier HJ, Faaber P, Fennis JF, van't Laar ATherapeutic efficacy of alpha-adrenoceptor blockade in primary and secondary Raynaud's syndrome.Angiology.(1984 Nov)
  11. ^Khouri C, Lepelley M, Bailly S, Blaise S, Herrick AL, Matucci-Cerinic M, Allanore Y, Trinquart L, Cracowski JL, Roustit MComparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials.Lancet Rheumatol.(2019 Dec)
  12. ^Thompson AE, Pope JECalcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.Rheumatology (Oxford).(2005 Feb)
  13. ^Arefiev K, Fiorentino DF, Chung LEndothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.Int J Rheumatol.(2011)
  14. ^Buecking A, Rougemont E, Fabio Zullino DTreatment of Raynaud's phenomenon with escitalopram.Int J Neuropsychopharmacol.(2005 Jun)
  15. ^Hu S, Hosoi M, Belcaro G, Dugall M, Feragalli B, Cotellese R, Luzzi RManagement of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.Minerva Cardioangiol.(2019 Oct)
  16. ^DiGiacomo RA, Kremer JM, Shah DMFish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.Am J Med.(1989 Feb)
  17. ^Ho M, Maple C, Bancroft A, McLaren M, Belch JJThe beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology.Prostaglandins Leukot Essent Fatty Acids.(1999 Jul)
  18. ^Shepherd AI, Costello JT, Bailey SJ, Bishop N, Wadley AJ, Young-Min S, Gilchrist M, Mayes H, White D, Gorczynski P, Saynor ZL, Massey H, Eglin CM"Beet" the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud's phenomenon.J Appl Physiol (1985).(2019 Nov 1)
  19. ^Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJOral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.Arthritis Rheum.(1997 Feb)
  20. ^Khan F, Belch JJSkin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.J Rheumatol.(1999 Nov)
  21. ^Correa MJ, Mariz HA, Andrade LE, Kayser COral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial.Rev Bras Reumatol.(2014 Nov-Dec)
  22. ^Wright, C.I. et alRaynaud's Phenomenon and the Possible Use of FoodsJournal of Food Science.(2006)
  23. ^Tesselaar E, Nezirevic Dernroth D, Farnebo SAcute effects of coffee on skin blood flow and microvascular function.Microvasc Res.(2017 Nov)
  24. ^Mahmood, F. et alRaynaud's Phenomenon and the Possible Use of Foods: Non-Pharmacological Interventions for the Treatment of Raynaud’s phenomenon—A Systematic ReviewUpdates in Family Medicine.(2024)
  25. ^Malenfant D, Catton M, Pope JEThe efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis.Rheumatology (Oxford).(2009 Jul)
  26. ^Zhou F, Huang E, Zheng E, Deng JThe use of acupuncture in patients with Raynaud's syndrome: a systematic review and meta-analysis of randomized controlled trials.Acupunct Med.(2023 Apr)
  27. ^Jobe JB, Sampson JB, Roberts DE, Beetham WP JrInduced vasodilation as treatment for Raynaud's disease.Ann Intern Med.(1982 Nov)
  28. ^Thune TH, Ladegaard L, Licht PBThoracoscopic sympathectomy for Raynaud's phenomenon--a long term follow-up study.Eur J Vasc Endovasc Surg.(2006 Aug)
  29. ^Buttolph A, Sapra AGangrene.StatPearls.(2024 Jan)
  30. ^Ruaro B, Sulli A, Smith V, Pizzorni C, Paolino S, Alessandri E, Cutolo MMicrovascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.Reumatismo.(2017 Dec 21)
  31. ^Wollina U, Koch A, Langner D, Hansel G, Heinig B, Lotti T, Tchernev GAcrocyanosis - A Symptom with Many Facettes.Open Access Maced J Med Sci.(2018 Jan 25)
  32. ^Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman ZESVM guidelines - the diagnosis and management of Raynaud's phenomenon.Vasa.(2017 Oct)
  33. ^Shah J, Billington AR, Elston JB, Payne WGRaynaud's Phenomenon.Eplasty.(2013)
Examine Database References
  1. Raynaud's Phenomenon Symptoms - Bredie SJ, Jong MCNo significant effect of ginkgo biloba special extract EGb 761 in the treatment of primary Raynaud phenomenon: a randomized controlled trialJ Cardiovasc Pharmacol.(2012 Mar)
  2. Raynaud's Phenomenon Symptoms - Choi WS, Choi CJ, Kim KS, Lee JH, Song CH, Chung JH, Ock SM, Lee JB, Kim CMTo compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study)Clin Rheumatol.(2009 May)
  3. Raynaud's Phenomenon Symptoms - DiGiacomo RA, Kremer JM, Shah DMFish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.Am J Med.(1989 Feb)
  4. Raynaud's Phenomenon Symptoms - Zhou F, Huang E, Zheng E, Deng JThe use of acupuncture in patients with Raynaud's syndrome: a systematic review and meta-analysis of randomized controlled trials.Acupunct Med.(2023 Apr)
  5. Endothelial Function - Shepherd AI, Costello JT, Bailey SJ, Bishop N, Wadley AJ, Young-Min S, Gilchrist M, Mayes H, White D, Gorczynski P, Saynor ZL, Massey H, Eglin CM"Beet" the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud's phenomenon.J Appl Physiol (1985).(2019 Nov 1)